BOOKS BY CATEGORY
Your Account
Modulation of Protein Stability in Cancer Therapy
Price
Quantity
£99.50
(To see other currencies, click on price)
Paperback / softback
Add to basket  

£99.50
(To see other currencies, click on price)
Add to basket  

MORE ABOUT THIS BOOK

Feature:

Chapters focus on the cellular and molecular mechanisms of various small-molecule compounds and inhibitors that target proteins that regulate the proteasome, ubiquitin ligases, ubiquitination pathway, and aggresome pathway in cancer


Back cover:

This book contains chapters written by experts in the field of the ubiquitin proteasome system and cancer.  The authors have summarized current information on ubiquitin ligases and proteasomes as potential targets for cancer therapy. Topics covered in the book include an overview of ubiquitin ligases, deubiquitinating enzymes, and the proteasome.  Specific diseases resulting from deregulated ubiquitin ligases, such as Von-Hippel-Lindau disease and Fanconi anemia are also discussed.  Finally, novel approaches and drugs to target proteins involved in sumoylation, ubiquitination, and degradation are described.


Contents:

Ubiquitin Ligases and Cancer.- The 26S Proteasome as a Therapeutic Target in Cancer: Beyond Protease Inhibitors?.- Targeting HAUSP: Killing Two Birds with One Stone.- Modulation of Protein Stability: Targeting the VHL Pathway.- Interrelationship of the Fanconi Anemia/BRCA Pathway.- Targeting the Sumoylation Pathway.- Proteasome Inhibitors.- Targeting Deubiquitinating Enzymes.- Proteolysis Targeting Chimeric Molecules.


PRODUCT DETAILS

ISBN-13: 9781441924018
Publisher: Springer (Springer New York)
Publication date: October, 2010
Pages: 175
Weight: 275g
Availability: POD
Subcategories: Biochemistry, Genetics, Immunology, Microbiology, Oncology
Related books
Publisher recommends

CUSTOMER REVIEWS

Average Rating